Dr Martens take steps towards financial recovery
The makers of the iconic Dr Martens footwear range said better sales in the US have signalled the start of the firm's recovery.
The company, based in Wollaston, Northamptonshire, saw its turnover drop by just 3% over the last three months of 2024
The figure for the last quarter of 2023 was 18%.
Doc Martens' new chief executive said he had "great confidence" for the year ahead.
The Dr Martens design originated in Germany in the 1940s and production started in the UK in 1959 when the Northamptonshire-based Griggs Group bought patent rights.
The familiar yellow-stitched boots, made at the factory in Cobbs Lane, Wollaston, have been bought by famous names from the Sex Pistols to the Dalai Lama.
The Pope's Swiss Guard were provided with Dr Martens boots during the Pontificate of John Paul II.
The firm has seen revenues drop in recent years, exacerbated by the cost-of-living crisis.
It has issued several profit warnings and replaced its chief executive.
The company's US revenue over the festive quarter fell 4% year on year, compared with 20% in the previous quarter.
Falls in European revenue also eased, from 18% in the previous quarter to 4% in last three months of 2024.
Dr Martens expects overall turnover for the full year to be down 9% compared with the previous year, at £599m.
Ije Nwokorie became chief executive of the company earlier this month and said he had "great confidence" for the year ahead.
He added that plans to reduce excess stock were "on track" and that the company continued to "actively manage our costs".
He said: "The team and I are squarely focused on returning the business to sustainable and profitable growth."
Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.